Acer Therapeutics Inc.
Boston, MA Acer Therapeutics Inc.
- UEI
- C6EKP8VELDC1
- CAGE
- 76BR6
- Primary NAICS
- 456110 Pharmacies and Drug Retailers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 101 Federal St 29th floor, Boston, MA 02110, USA
- Website
- zevra.com
- Founded
- 2006
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
About Acer Therapeutics Inc.
Acer Therapeutics Inc. is a for-profit corporate entity registered in the System for Award Management (SAM.gov) since July 19, 2014, with its registration valid until February 24, 2026. The company specializes in pharmaceutical products, focusing on the development and distribution of drugs and medical treatments, particularly in the areas of hematology and specific pharmaceutical medications. Their primary federal contract offerings center on the provision of specialized pharmaceutical products, with a specific focus on medications like MIPLYFFA and OLPRUVA, which are supplied to federal agencies through various contracting mechanisms.
The company has secured multiple Federal Supply Schedule (FSS) contract IDVs, primarily through the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. These contracts include a $1,891,583.25 Blanket Purchase Agreement with the National Acquisition Center for MIPLYFFA and OLPRUVA, awarded on July 8, 2025, with a performance period through July 7, 2026. Additionally, Acer Therapeutics holds two contracts with the Veterans Integrated Service Network 12 (VISN 12): a $225,000 multiple-award FSS contract from January 1, 2024, to December 31, 2028, for drugs, pharmaceuticals, and hematology-related products, and a previous $25,000 interim agreement under Schedule 65 I B that ran through December 31, 2023. These contracts demonstrate the company's ability to provide pharmaceutical products to federal agencies through pre-negotiated pricing and terms, with no specific set-asides applied to the contracts.
Contract vehicles
Quick answers
What is Acer Therapeutics Inc.'s UEI?
Acer Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is C6EKP8VELDC1.
What is Acer Therapeutics Inc.'s CAGE code?
Acer Therapeutics Inc.'s CAGE code is 76BR6.
What is Acer Therapeutics Inc.'s primary NAICS code?
Acer Therapeutics Inc.'s primary NAICS code is 456110 (Pharmacies and Drug Retailers).
Where is Acer Therapeutics Inc. located?
Acer Therapeutics Inc.'s physical address in SAM.gov is 101 Federal St 29th floor, Boston, MA 02110, USA.
Is Acer Therapeutics Inc. registered in SAM.gov?
Yes. Acer Therapeutics Inc.'s SAM.gov registration is active through August 28, 2027.
Which contract vehicles does Acer Therapeutics Inc. hold?
Acer Therapeutics Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Acer Therapeutics Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors